Q19 - The Role of Pharmacogenomics and Opioid Prescribing for Infants with Surgical Congenital Heart Disease: A Single-Center Pilot Study

Oral Presenter(s)

• 

  Ruby Barq, MD (she/her/hers)

  Postdoctoral Research Fellow, General Surgery Resident
  Children's Hospital Los Angeles, Virginia Commonwealth University Health
  Los Angeles, California, United States

Co-Author(s)

• SO

  Shadassa Ourshalimian, MPH

  Biostatistician
  Children's Hospital Los Angeles
  Los Angeles, California, United States
• SM

  Simran Maggo, PhD

  Assistant Professor
  School of Pharmacy, Shenandoah University
  Winchester, Virginia, United States
• OK

  Olivia A. Keane, MD, MS

  General Surgery Resident Physician
  Emory University School of Medicine
  Atlanta, Georgia, United States
• JN

  Jenny Q. Nguyen

  Children's hospital Los Angeles
  Westminster, California, United States
• MD

  Matthew Deardorff

  MD, PhD
  Children's Hospital Los Angeles
  Los Angeles, California, United States
• TL

  Tamorah Lewis

  The Hospital for Sick Children
  Toronto, Ontario, Canada
• AL

  Ashwini Lakshmanan, MD, MS, MPH, FAAP

  KPSOM
  Pasadena, California, United States
• SM

  Scott A. Mosley, PharmD

  Assistant Professor of Clinical Pharmacy
  USC Mann School of Pharmacy and Pharmaceutical Sciences
  Alhambra, California, United States
• LK

  Lorraine I. Kelley-Quon, MD MSHS

  Assistant Professor, Division of Pediatric Surgery and Population and Public Health Sciences
  Children's Hospital Los Angeles
  Los Angeles, California, United States